The heterogeneity of cancer significantly impacts treatment strategies. For instance, targeted therapies may be effective against certain subpopulations of cancer cells but not others. Similarly, resistance to treatment can develop as different subpopulations of cells adapt and evolve. This highlights the need for personalized medicine, where treatments are tailored to the specific characteristics of an individual's cancer.
